A Retrospective Observational Study to describe the Effectiveness and Safety of Vedolizumab With or Without Budesonide Induction Therapy Among Patients with Moderate to Severe Crohn’s Disease (Vedo-BuDy) First published 24/04/2019 Last updated 02/07/2024 EU PAS number:EUPAS28791 Study Finalised